Innate Pharma SA
F:IDDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
F:IDDA
|
FR |
|
C
|
Cronos Group Inc
F:7CI
|
CA |
Shareholder Yield
Current shareholder yield for
IDDA is
.
Peers Comparison
Shareholder Yield
Price Appreciation
IDDA Price
Innate Pharma SA
| Average Annual Return | -11.54% |
| Standard Deviation of Annual Returns | 23.79% |
| Max Drawdown | -86% |
| Market Capitalization | 144.3m EUR |
| Shares Outstanding | 80 950 800 |
| Percentage of Shares Shorted |
N/A
|